259 related articles for article (PubMed ID: 25269472)
21. Negative Regulation of the Keap1-Nrf2 Pathway by a p62/Sqstm1 Splicing Variant.
Kageyama S; Saito T; Obata M; Koide RH; Ichimura Y; Komatsu M
Mol Cell Biol; 2018 Apr; 38(7):. PubMed ID: 29339380
[TBL] [Abstract][Full Text] [Related]
22. Sequestosome 1/p62 facilitates HER2-induced mammary tumorigenesis through multiple signaling pathways.
Cai-McRae X; Zhong H; Karantza V
Oncogene; 2015 Jun; 34(23):2968-77. PubMed ID: 25088198
[TBL] [Abstract][Full Text] [Related]
23. Stimulation of GSH synthesis to prevent oxidative stress-induced apoptosis by hydroxytyrosol in human retinal pigment epithelial cells: activation of Nrf2 and JNK-p62/SQSTM1 pathways.
Zou X; Feng Z; Li Y; Wang Y; Wertz K; Weber P; Fu Y; Liu J
J Nutr Biochem; 2012 Aug; 23(8):994-1006. PubMed ID: 21937211
[TBL] [Abstract][Full Text] [Related]
24. Role of the Keap1-Nrf2 pathway in cancer.
Leinonen HM; Kansanen E; Pölönen P; Heinäniemi M; Levonen AL
Adv Cancer Res; 2014; 122():281-320. PubMed ID: 24974185
[TBL] [Abstract][Full Text] [Related]
25. Toll-Like Receptor Signaling Induces Nrf2 Pathway Activation through p62-Triggered Keap1 Degradation.
Yin S; Cao W
Mol Cell Biol; 2015 Aug; 35(15):2673-83. PubMed ID: 26012548
[TBL] [Abstract][Full Text] [Related]
26. Dihydrotanshinone I inhibits ovarian tumor growth by activating oxidative stress through Keap1-mediated Nrf2 ubiquitination degradation.
Sun C; Han B; Zhai Y; Zhao H; Li X; Qian J; Hao X; Liu Q; Shen J; Kai G
Free Radic Biol Med; 2022 Feb; 180():220-235. PubMed ID: 35074488
[TBL] [Abstract][Full Text] [Related]
27. NEDD4L inhibits migration, invasion, cisplatin resistance and promotes apoptosis of bladder cancer cells by inactivating the p62/Keap1/Nrf2 pathway.
Wu Q; Zhang H; You S; Xu Z; Liu X; Chen X; Zhang W; Ye J; Li P; Zhou X
Environ Toxicol; 2023 Jul; 38(7):1678-1689. PubMed ID: 37087754
[TBL] [Abstract][Full Text] [Related]
28. Tolerance to endoplasmic reticulum stress mediates cisplatin resistance in human ovarian cancer cells by maintaining endoplasmic reticulum and mitochondrial homeostasis.
Xu Y; Wang C; Su J; Xie Q; Ma L; Zeng L; Yu Y; Liu S; Li S; Li Z; Sun L
Oncol Rep; 2015 Dec; 34(6):3051-60. PubMed ID: 26398138
[TBL] [Abstract][Full Text] [Related]
29. Dissection of the role of p62/Sqstm1 in activation of Nrf2 during xenophagy.
Ishimura R; Tanaka K; Komatsu M
FEBS Lett; 2014 Mar; 588(5):822-8. PubMed ID: 24492006
[TBL] [Abstract][Full Text] [Related]
30. p62/SQSTM1 is required for the protection against endoplasmic reticulum stress-induced apoptotic cell death.
Park JS; Oh SY; Lee DH; Lee YS; Sung SH; Ji HW; Lee MJ; Lee YH; Rhee SG; Bae SH
Free Radic Res; 2016 Dec; 50(12):1408-1421. PubMed ID: 27780373
[TBL] [Abstract][Full Text] [Related]
31. Inhibition of p62/SQSTM1 sensitizes small-cell lung cancer cells to cisplatin-induced cytotoxicity by targeting NEDD9 expression.
Xu L; Xu F; Kong Q; Yang T; Tan D; Zhang X; Li N; Zhao S; Zhao J; Li M
Mol Carcinog; 2020 Aug; 59(8):967-979. PubMed ID: 32424979
[TBL] [Abstract][Full Text] [Related]
32. Oxaliplatin activates the Keap1/Nrf2 antioxidant system conferring protection against the cytotoxicity of anticancer drugs.
Wang XJ; Li Y; Luo L; Wang H; Chi Z; Xin A; Li X; Wu J; Tang X
Free Radic Biol Med; 2014 May; 70():68-77. PubMed ID: 24556415
[TBL] [Abstract][Full Text] [Related]
33. Isodeoxyelephantopin induces protective autophagy in lung cancer cells via Nrf2-p62-keap1 feedback loop.
Wang Y; Zhang J; Huang ZH; Huang XH; Zheng WB; Yin XF; Li YL; Li B; He QY
Cell Death Dis; 2017 Jun; 8(6):e2876. PubMed ID: 28617433
[TBL] [Abstract][Full Text] [Related]
34. Effect of p62/SQSTM1 polyubiquitination on its autophagic adaptor function and cellular survival under oxidative stress induced by arsenite.
Lee H; Kim MN; Ryu KY
Biochem Biophys Res Commun; 2017 May; 486(3):839-844. PubMed ID: 28359760
[TBL] [Abstract][Full Text] [Related]
35. MOAP-1-mediated dissociation of p62/SQSTM1 bodies releases Keap1 and suppresses Nrf2 signaling.
Tan CT; Chang HC; Zhou Q; Yu C; Fu NY; Sabapathy K; Yu VC
EMBO Rep; 2021 Jan; 22(1):e50854. PubMed ID: 33393215
[TBL] [Abstract][Full Text] [Related]
36. Chemotherapeutic resistance of head and neck squamous cell carcinoma is mediated by EpCAM induction driven by IL-6/p62 associated Nrf2-antioxidant pathway activation.
Noman ASM; Parag RR; Rashid MI; Islam S; Rahman MZ; Chowdhury AA; Sultana A; Jerin C; Siddiqua A; Rahman L; Nayeem J; Akther S; Baidya S; Shil RK; Rahman M; Shirin A; Mahmud R; Hossain SMI; Sumi SA; Chowdhury A; Basher SB; Hasan A; Bithy S; Aklima J; Chowdhury N; Hasan MN; Banu T; Chowdhury S; Hossain MM; Yeger H; Farhat WA; Islam SS
Cell Death Dis; 2020 Aug; 11(8):663. PubMed ID: 32814771
[TBL] [Abstract][Full Text] [Related]
37. Induction of ferroptosis by ATF3 elevation alleviates cisplatin resistance in gastric cancer by restraining Nrf2/Keap1/xCT signaling.
Fu D; Wang C; Yu L; Yu R
Cell Mol Biol Lett; 2021 Jun; 26(1):26. PubMed ID: 34098867
[TBL] [Abstract][Full Text] [Related]
38. p62 promotes bladder cancer cell growth by activating KEAP1/NRF2-dependent antioxidative response.
Li T; Jiang D; Wu K
Cancer Sci; 2020 Apr; 111(4):1156-1164. PubMed ID: 31967368
[TBL] [Abstract][Full Text] [Related]
39. An FTLD-associated SQSTM1 variant impacts Nrf2 and NF-κB signalling and is associated with reduced phosphorylation of p62.
Foster A; Scott D; Layfield R; Rea SL
Mol Cell Neurosci; 2019 Jul; 98():32-45. PubMed ID: 30954537
[TBL] [Abstract][Full Text] [Related]
40. Physical and functional interaction of sequestosome 1 with Keap1 regulates the Keap1-Nrf2 cell defense pathway.
Copple IM; Lister A; Obeng AD; Kitteringham NR; Jenkins RE; Layfield R; Foster BJ; Goldring CE; Park BK
J Biol Chem; 2010 May; 285(22):16782-8. PubMed ID: 20378532
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
